Volume 2, Issue 1 - 2026

Open AccessOpinion

Can Substance-Induced Psychoses (SIP) Shed Light on the Paradigm of Schizophrenia?

Alessio Mosca, Filippo Maria Ferro

2026, 2(1): 5. doi: 10.53941/cna.2026.100005

11 Downloaded

27 Viewed

Download PDF

Open AccessSystematic Review

Aripiprazole Long Acting and Clozapine: Between Efficacy and Tolerability

Luca Persico, Ludovica Di Sante, Michele Xynelis, Andrea Miuli, Alessio Mosca, Mauro Pettorruso

2026, 2(1): 4. doi: 10.53941/cna.2026.100004

18 Downloaded

65 Viewed

Download PDF

Open AccessReview

Brexpiprazole in the Management of Schizophrenia and Comorbid Substance Use Disorders: A Narrative Review of Efficacy, Safety, and Real-World Evidence (2020–2026)

Miriam Olivola, Nicolaja Girone, Andrea Crippa, Monica Macellaro, Vassilis Martiadis, Fabiola Raffone, Tiziano Prodi, Natascia Brondino, Roberta Anniverno, Bernardo Dell’Osso

2026, 2(1): 3. doi: 10.53941/cna.2026.100003

27 Downloaded

117 Viewed

Download PDF

Open AccessArticle

Improved Migraine Disability, Sleep Quality, and Well-Being in Individuals with Chronic Migraine Self-Administering Artisanal or Industrial Full-Spectrum Cannabidiol-Rich Oils: An Observational Cohort Study

Linério Ribeiro de Novais Júnior, Larissa Mendes da Silva, Vicente Meneguzzo, Suelen de Souza Ramos, Lara Rodrigues da Rosa, Tiago Odilio de Souza, João Victor Simão, Alisson Reuel da Silva, Josiel Mack, Kelser de Souza Kock, Mariana Pereira de Souza Goldim, Antonio Inserra, Rafael Mariano de Bitencourt

2026, 2(1): 2. doi: 10.53941/cna.2026.100002

51 Downloaded

271 Viewed

Download PDF

Open AccessArticle

Ketamine-Related Deaths Registered in Scotland 2013–2024

John Martin Corkery, Amira Guirguis, Fabrizio Schifano

2026, 2(1): 1. doi: 10.53941/cna.2026.100001

42 Downloaded

174 Viewed

Download PDF